Back to search

National and Kapodistrian University of Athens

Διερεύνηση οικογενειών με βεβαρημένο οικογενειακό ιστορικό καρκίνου με αρνητική ανάλυση πάνελ 36 γονιδίων χρησιμοποιώντας exome sequencing και polygenic risk score (PRS)

Abstract

dc:description

Introduction: Hereditary cancer accounts for approximately 5–10% of all cancer cases. Over the past decade, technological advancements, particularly the advent of Next Generation Sequencing (NGS), have enabled the analysis of many more genes associated with hereditary cancer predisposition. The aim of this doctoral thesis is: A) to retrospectively evaluate the clinical utility of polygenic risk score (PRS) estimation in the development of breast cancer, using a cohort of patients already diagnosed with breast cancer, and B) to potentially identify new genetic loci associated with hereditary breast cancer through whole-exome sequencing (WES).Materials and Methods: Between 2020 and 2023, a total of 8,261 individuals were referred for multigene panel testing of 52 genes using NGS at the Genekor Medical S.A. laboratory. Subsequently, among the 4,641 patients with breast cancer, PRS analysis was conducted in 105 individuals with known results from targeted genetic testing, analyzing 577,113 single nucleotide polymorphisms (SNPs). Additionally, in order to clarify the genetic cause of breast cancer, WES analysis was performed on 85 women (excluding those positive for a high-penetrance gene).Results:20% of the individuals tested carried a pathogenic variant. Specifically, 54.8% of patients had a pathogenic variant in a clinically significant gene (including BRCA1, BRCA2, PALB2, RAD51C, PMS2, CDKN2A, MLH1, MSH2, TP53, MSH6, APC, RAD51D, PTEN, RET, CDH1, MEN1, and VHL). Among the various types of pathogenic variants detected, a significant proportion (6.52%) represented large genomic rearrangements (Copy Number Variations - CNVs).The PRS analysis showed a significant difference in the distribution of PRS percentiles, indicating a higher risk of developing breast cancer in the study group compared to the general population. Higher PRS values were observed in women who developed the disease at a younger age and those with a family history of breast cancer. Among patients with a detected pathogenic variant, lower PRS values were observed, as the risk of developing breast cancer was primarily due to monogenic etiology. Through WES analysis, the following findings were identified:CTC1: c.880C>T, p.(Gln294*)MLH3: c.405del, p.(Asp136Metfs*2)PPM1D: c.1426_1430del, p.(Glu476Leufs*3)SDHB: c.395A>G, p.(His132Arg) Conclusions: Comprehensive genetic testing is essential, as it can provide information relevant to the clinical management of individuals carrying pathogenic variants. Moreover, the calculation of PRS is particularly useful in women with a family history of breast cancer when no monogenic etiology is identified through NGS.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsoulos, Nikolaos
  • Τσούλος, Νικόλαος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58915

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsoulos, Nikolaos; Τσούλος, Νικόλαος. Διερεύνηση οικογενειών με βεβαρημένο οικογενειακό ιστορικό καρκίνου με αρνητική ανάλυση πάνελ 36 γονιδίων χρησιμοποιώντας exome sequencing και polygenic risk score (PRS). National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/58915